Arkolith/Insider Trading/PBYI/Form 4

Stuglik Brian M

DirectorPUMA BIOTECHNOLOGY, INC. (PBYI) · full profile →Form 4 · filed Jun 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$27K
Net Open-Market Flow
-$27K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2025Sell(S)8K$3.39$27K95K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-020719) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML